About this trial
This is a single-center, randomized controlled study. The aim of this study is to compare the impact of left bundle branch area pacing versus traditional right ventricular pacing on the incidence of atrial fibrillation in patients with atrioventricular block.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Adult patients aged 18-85;
AV block patients with ventricular pacing indications and the expected rate of ventricular pacing(VP)> 40%, including (a) third-degree AV block; (b) second degree AV block (type II); (c) intermittent advanced AV block with expected VP>40%; (d) symptomatic first degree AV block and PR interval on ECG > 300ms;
Signed informed consent;
Disqualifiers
Baseline echocardiographic assessment of patients with impaired LV function (LVEF<50%);
Patients with the history of atrial fibrillation;
Having difficulties in follow-up: Those who cannot accept 2-year follow-up on time due to physical condition or other reasons;
Pacemaker replacement without new implanted ventricular electrodes;
Trial design
Parallel
Treatments tested in this trial
left bundle branch area pacing
Procedure/SurgeryLeft bundle branch area pacing(LBBAP) is a novel physiological pacing form for ventricular pacing. In patients received LBBAP, the pacing lead will be placed at left bundle branch area to achieve narrow paced QRS duration.
right ventricular pacing
Procedure/SurgeryRight ventricular pacing is the traditional pacing modality for ventricular pacing. The pacing lead was placed in the apex or septum of right ventricle.
Treatment groups
Trial outcomes
Primary outcomes
the incidence of new-onset atrial fibrillation
Secondary outcomes
all-cause mortality
hospitalization for heart failure
an device upgrade for heart failure
alteration of quality of life score
Sponsors and contacts
Click on the lead sponsor to view all of their trials.